Cargando...
Cardiotoxicity of anthracycline therapy: current perspectives
Anthracyclines, especially doxorubicin and daunorubicin, are the drugs of first choice in the treatment of patients with hematologic malignancies, soft-tissue sarcomas, and solid tumors. Unfortunately, the use of anthracyclines is limited by their dose-dependent and cumulative cardiotoxicity. The mo...
Gardado en:
| Publicado en: | Arch Med Sci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Termedia Publishing House
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4848373/ https://ncbi.nlm.nih.gov/pubmed/27186191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2016.59270 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|